A detailed history of Versant Capital Management, Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 42 shares of NBIX stock, worth $5,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Previous 56 25.0%
Holding current value
$5,277
Previous $7,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$114.58 - $153.15 $1,604 - $2,144
-14 Reduced 25.0%
42 $4,000
Q2 2024

Jul 05, 2024

BUY
$130.86 - $143.19 $6,412 - $7,016
49 Added 700.0%
56 $7,000
Q4 2023

Jan 08, 2024

BUY
$106.07 - $132.76 $318 - $398
3 Added 75.0%
7 $0
Q3 2023

Oct 11, 2023

SELL
$94.02 - $117.1 $470 - $585
-5 Reduced 55.56%
4 $0
Q2 2023

Jul 10, 2023

BUY
$89.53 - $104.87 $447 - $524
5 Added 125.0%
9 $0
Q1 2023

Apr 10, 2023

SELL
$94.11 - $123.02 $658 - $861
-7 Reduced 63.64%
4 $0
Q1 2022

Apr 29, 2022

BUY
$72.45 - $94.81 $796 - $1,042
11 New
11 $1,000
Q3 2021

Oct 29, 2021

SELL
$86.18 - $99.03 $258 - $297
-3 Closed
0 $0
Q2 2021

Jul 22, 2021

BUY
$89.43 - $102.27 $268 - $306
3 New
3 $0

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.